Literature DB >> 26957263

A potential clinical usefulness of measuring serum bilirubin levels in patients with polymyositis.

Y-F Peng1, L Zhang, G-G Pan, Y-S Wei.   

Abstract

OBJECTIVE: Accumulated data have indicated that bilirubin has antiinflammatory, antioxidative, and immunosuppressive properties. Polymyositis (PM) belongs to an autoimmune disease characterized by chronic inflammation in skeletal muscle. Until now, to the best of our knowledge, there are no literature investigating bilirubin levels in patients with PM. Therefore, the aim of this investigation was to assess a relationship between bilirubin and PM. PATIENTS AND METHODS: Our study included newly diagnosed 77 patients with PM who were admitted to the Affiliated Hospital of Youjiang Medical University for Nationalities (Guangxi, China) and 108 healthy subjects as controls. Clinical characteristics and laboratory parameters of patients were analyzed, retrospectively.
RESULTS: The serum concentrations of total bilirubin (TB), conjugate bilirubin (CB), unconjugated bilirubin (UCB) were significantly lower in patients with PM than healthy controls. Serum concentrations of TB were negatively correlated with erythrocyte sedimentation rate (ESR), creatine kinase (CK) and lactic dehydrogenase (LDH) in patients with PM (r=-0.494, p<0.001; r=-0.274, p=0.017; r=-0.282, p=0.014), and serum concentrations of UCB were negatively correlated with ESR and CK in PM patients (r=-0.424, p<0.001; r=-0.234, p=0.041). Both serum TB and UBC concentrations were positively correlated with manual muscle test (MMT) score in patients with PM (r=0.328, p=0.004; r=0.333, p=0.004). In multiple linear regression analysis, serum UBC levels were independently associated with MMT score (r=0.239, p=0.003).
CONCLUSIONS: We observed significantly lower serum concentrations of TB, CB and UCB in patients with PM, and suggested a potential association between serum concentrations of UBC and disease activity in PM patients.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26957263

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  Low serum bilirubin, albumin, and uric acid levels in patients with Crohn's disease.

Authors:  Qisheng Su; Xiaohong Li; Wuning Mo; Zheng Yang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

2.  Clinical Significance of Serum Bilirubin in Behçet's Disease.

Authors:  Tuba Tülay Koca
Journal:  J Transl Int Med       Date:  2018-12-31

3.  Clinical significance of serum bilirubin in primary Sjögren syndrome patients.

Authors:  Zunni Zhang; Qisheng Su; Liqian Zhang; Zheng Yang; Yuling Qiu; Wuning Mo
Journal:  J Clin Lab Anal       Date:  2019-11-06       Impact factor: 3.124

4.  Decreased Bilirubin is Associated With Disease Activity of Primary Sjögren's Syndrome.

Authors:  Jing Xie; Zhencheng Zhang; Yan Liang; Zaixing Yang
Journal:  Arch Rheumatol       Date:  2020-01-08       Impact factor: 1.472

5.  The significance of routine biochemical markers in patients with major depressive disorder.

Authors:  You-Fan Peng; Yang Xiang; Ye-Sheng Wei
Journal:  Sci Rep       Date:  2016-09-29       Impact factor: 4.379

6.  Associations between serum bilirubin levels and essential trace elements status in an adult population.

Authors:  You-Fan Peng; Ye-Sheng Wei
Journal:  Oncotarget       Date:  2017-06-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.